Tagrisso recommended for approval in the EU for unresectable EGFR-mutated lung cancer
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Hospital business revenues increase 13.9% to Rs. 1,655 crore
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated